SG&A Expense (Quarterly) Chart

View SG&A Expense (Quarterly) for LNAI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (Quarterly) Chart
Start Trial

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2012. Start Trial.
Date Value
March 31, 2026 1.421M
December 31, 2025 1.766M
September 30, 2025 2.410M
June 30, 2025 4.001M
March 31, 2025 4.225M
December 31, 2024 4.353M
September 30, 2024 5.301M
June 30, 2024 4.999M
March 31, 2024 7.652M
December 31, 2023 3.616M
September 30, 2023 8.290M
June 30, 2023 2.952M
March 31, 2023 3.796M
December 31, 2022 4.013M
September 30, 2022 4.557M
June 30, 2022 3.160M
March 31, 2022 2.790M
December 31, 2021 4.155M
September 30, 2021 4.467M
June 30, 2021 2.079M
March 31, 2021 1.944M
December 31, 2020 1.94M
September 30, 2020 1.778M
June 30, 2020 1.498M
March 31, 2020 1.487M
Date Value
December 31, 2019 2.235M
September 30, 2019 1.869M
June 30, 2019 1.521M
March 31, 2019 1.952M
December 31, 2018 3.580M
September 30, 2018 1.252M
June 30, 2018 0.8286M
March 31, 2018 2.339M
December 31, 2017 1.057M
September 30, 2017 0.4682M
June 30, 2017 0.6291M
March 31, 2017 0.3312M
December 31, 2016 0.5314M
September 30, 2016 0.8314M
June 30, 2016 0.4785M
March 31, 2016 0.274M
December 31, 2015 0.3386M
September 30, 2015 0.2357M
March 31, 2015 0.665M
December 31, 2014 0.8606M
September 30, 2014 0.3655M
June 30, 2014 0.5009M
June 30, 2013 0.0025M
March 31, 2013 0.0094M
December 31, 2012 0.0096M

SG&A Expense (Quarterly) Range, Past 5 Years

View SG&A Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (Quarterly) Benchmarks

View SG&A Expense (Quarterly) Benchmarks
Start Trial
Agenus, Inc. 6.86M
Amgen, Inc. 1.602B
BioCryst Pharmaceuticals, Inc. 94.55M
Imunon, Inc. 1.969M
Curis, Inc. 5.07M